SCYRF (NorthPalm Capital) Research & Development: $-0.13 Mil (TTM As of Mar. 2026)


SCYRF NorthPalm Capital Corp SCYRF
40 GF Score
Price $0.08
GF Value $0.02
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is NorthPalm Capital Research & Development?

NorthPalm Capital SCYRF 40 Research & Development is $-0.13 Mil as of Mar. 2026. GuruFocus rates SCYRF with a GF Score™ of 40/100 and a GF Value™ of $0.02 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. NorthPalm Capital's Research & Development for the three months ended in Mar. 2026 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.13 Mil.

NorthPalm Capital  (OTCPK:SCYRF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

NorthPalm Capital Research & Development Related Terms

NorthPalm Capital Research & Development Historical Data

* Premium members only.

The historical data trend for NorthPalm Capital's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NorthPalm Capital Research & Development Chart

NorthPalm Capital Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.42 0.54 0.88 0.96 0.16

NorthPalm Capital Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.08 -0.21 0.00 0.00
SCYRF
40GF Score
NorthPalm Capital Corp SCYRF
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

NorthPalm Capital Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.13 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $-0.13 Mil mean?
NorthPalm Capital (SCYRF) has a Research & Development of $-0.13 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on NorthPalm Capital and its competitors.
Is NorthPalm Capital's Research & Development too high?
NorthPalm Capital's current Research & Development is $-0.13 Mil. Overall, NorthPalm Capital has a GF Score™ of 40/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does NorthPalm Capital's Research & Development compare to BLK and BX?
NorthPalm Capital's Research & Development of $-0.13 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Asset Management company?
A good Research & Development depends on the Asset Management industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on NorthPalm Capital and its competitors. NorthPalm Capital's current Research & Development is $-0.13 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NorthPalm Capital stock overvalued right now?
Based on GuruFocus' analysis, NorthPalm Capital (SCYRF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.02, compared to a current price of $0.08 — trading 291% above its estimated fair value. The current Research & Development is $-0.13 Mil. NorthPalm Capital's overall GF Score™ is 40/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For NorthPalm Capital (SCYRF), the current Research & Development is $-0.13 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is NorthPalm Capital (SCYRF) Overvalued in 2026?

Based on GuruFocus' analysis, NorthPalm Capital stock appears to be overvalued. The current stock price of $0.08 is trading 291% above its estimated GF Value™ of $0.02. GuruFocus considers NorthPalm Capital to be Significantly Overvalued.

Key valuation signals for SCYRF:

  • Research & Development: $-0.13 Mil
  • GF Value™: $0.02 vs. price of $0.08 (291% above fair value)
  • GF Score™: 40/100 with 6 warning signs

No single metric tells the full story. See the SCYRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

NorthPalm Capital Business Description

Other Exchanges EIY:GermanyNP:Canada
Address 1215 Queensway East, Unit 54, Mississauga, ON, CAN, L4Y 0G4
NorthPalm Capital Corp invests in and actively supports a growing portfolio of pioneering and high-upside ventures across the technology sector. It identifies and invests in high-growth opportunities to compound shareholder value over time. The group offers shareholders direct participation in a research-led, AI-augmented investment idea, actively sourcing and allocating capital into high-potential opportunities with discipline.
40GF Score

Get the complete analysis for SCYRF

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.08
Price
$0.02
GF Value